Long-Term Efficacy and Safety of Quadruple Therapy in Childhood Diffuse Proliferative Lupus Nephritis

REFERENCES

• Petty RE, Laxer RM. Systemic lupus erythematosus. Textbook of Pediatric Rheumatology5^th, JT Cassidy, RE Petty, RM Laxer, CB Lindsley. Elsevier Saunders, Philadelphia 2005; 342–391
   Google Scholar
• Gitelman MK, Reiff A, Silverman ED. Systemic lupus erythematosus in childhood. Rheum Dis Clin N Am. 2002; 28: 561–577
   Google Scholar
• Niaudet P, Salomon R. Systemic lupus erythematosus. Pediatric Nephrology5^th, ED Avner, WE Harmon, P Niaudet. Lippincott Williams & Wilkins, Philadelphia 2004; 865–886
   Google Scholar
• Kashgarian M. Lupus nephritis: Lessons from the path lab (Nephrology forum). Kidney Int. 1994; 45: 928–938
   PubMed Web of Science ®Google Scholar
• Niaudet P. Treatment of lupus nephritis in children. Pediatr Nephrol. 2000; 14: 158–166
   PubMed Web of Science ®Google Scholar
• Boumpas DT. Lupus nephritis. Nephrol Dial Transplant. 2001; 16(Suppl. 6)55–57
   Google Scholar
• Tan EM, Cohen AS, Fies JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271–1277
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Banfi G, Moroni G. Systemic lupus erythematosus (clinical). Oxford Textbook of Clinical Nephrology2^nd, AM Davison, JS Cameron, JP Grünfeld, DNS Kerr, E Ritz, CG Winearls. Oxford University Press, New York 1998; 935–959
   Google Scholar
• Austin HA, Klippel JH, Balow JE, Leriche NG, Steinberg AG. Therapy of lupus nephritis. N Engl J Med. 1986; 314: 614–619
   PubMed Web of Science ®Google Scholar
• Erdoğan Ö, Öner A, Demircin G, et al. A boy with consecutive development of SLE and Wegener granulomatosis. Pediatr Nephrol. 2004; 19: 438–441
   Google Scholar
• Bogdanovic R, Nikolic V, Pasic S, et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol. 2004; 19: 36–44
   PubMed Web of Science ®Google Scholar
• Zappitelli M, Duffy C, Bernard C, et al. Clinicopathological study of the WHO classification in childhood lupus nephritis. Pediatr Nephrol. 2004; 19: 503–510
   PubMedGoogle Scholar
• Dixit MP, Bracamonte E, Dixit N. Intravenous cyclophosphamide-resistant systemic lupus erythematosus in Arizona. Pediatr Nephrol. 2004; 19: 738–743
   Google Scholar
• Wright EC, Tullus K, Dillon MJ. Retrospective study of plasma exchange in children with systemic lupus erythematosus. Pediatr Nephrol. 2004; 19: 1108–1114
   Google Scholar
• Cameron JS. Nephritis of systemic lupus erythematosus. Pediatric Kidney Disease2^nd, CM Edelmann. Little Brown and Company, Boston 1992; 1407–1465
   Google Scholar
• Crespo MRG, Fernandez JIL, Usera G, Poveda MJ, Reino JJG. Outcome of silent lupus nephritis. Semin Arthritis Rheum. 1996; 26: 468–476
   Google Scholar
• Kuiper-Geertsma DG, Derksen RHWM. Newer drugs for the treatment of lupus nephritis. Drugs. 2003; 63: 167–180
   PubMed Web of Science ®Google Scholar
• Hebert LA. Management of lupus nephropathy. Nephron Clin Pract. 2003; 93: c7–c12
   Google Scholar
• Ioannidis JPA, Boki KA, Katsorida ME, et al. Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int. 2000; 57: 258–264
   PubMed Web of Science ®Google Scholar
• Hernandez JC, Ros JO, Labrador M, et al. Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methyl prednisolone. Lupus. 2003; 12: 287–296
   Google Scholar
• Barbano G, Gusmano R, Damasio B, et al. Childhood onset lupus nephritis: A single-center experience of pulse intravenous cyclophosphamide therapy. J Nephrol. 2002; 15: 123–129
   PubMed Web of Science ®Google Scholar
• Hejaili FF, Moist LM, Clark WF. Treatment of lupus nephritis. Drugs. 2003; 63: 257–274
   Google Scholar
• Lehman TJA, Edelheit BS, Onel KB. Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Ann Rheum Dis. 2004; 63: 321–323
   PubMedGoogle Scholar
• Suzuki K, Tanaka H, Tsugawa K, Ito E. Effective treatment with cyclosporine A of a child with systemic lupus erythematosus resistant to cyclophosphamide pulse therapy. Thoku J Exp Med. 2006; 208: 355–359
   Google Scholar
• Glicklich D, Acharya A. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide. Am J Kidney Dis. 1998; 32: 318–322
   PubMed Web of Science ®Google Scholar
• Duddridge M, Powell RJ. Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. Ann Rheum Dis. 1997; 56: 690–692
   PubMed Web of Science ®Google Scholar
• Edelbauer M, Jungraithmayr T, Zimmerhackl LB. Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression. Pediatr Nephrol. 2005; 20: 811–813
   PubMed Web of Science ®Google Scholar
• Bakkaloğlu A. Lupus nephropathy in children. Nephrol Dial Transplant. 2001; 16(Suppl. 6)126–128
   Google Scholar
• Singh S, Devidayal, Kumar L, Joshi K. Mortality patterns in childhood lupus—10 years’ experience in a developing country. Clin Rheumatol. 2002; 21: 462–465
   Google Scholar
• Bakr A. Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt. Pediatr Nephrol. 2005; 20: 1081–1086
   PubMed Web of Science ®Google Scholar
• Sumboonnanonda A, Vongjirad A, Suntornpoch V, Laohapand T, Parichatikanond P. Renal pathology and long-term outcome in childhood SLE. J Med Assoc Thai. 1998; 81: 830–834
   Google Scholar
• Hagelberg S, Lee Y, Bargman J, et al. Long-term follow-up of childhood lupus nephritis. J Rheumatol. 2002; 29: 2635–2642
   PubMed Web of Science ®Google Scholar
• Emre S, Bilge I, Şirin A, et al. Lupus nephritis in children: Prognostic significance of clinicopathological findings. Nephron. 2001; 87: 118–126
   PubMed Web of Science ®Google Scholar
• Lee BS, Cho HY, Kim EJ, et al. Clinical outcomes of childhood lupus nephritis: A single center's experience. Pediatr Nephrol. 2007; 22: 222–231
   PubMed Web of Science ®Google Scholar
• Askenazi D, Myones B, Kamdar A, et al. Outcomes of children with proliferative lupus nephritis: The role of protocole renal biopsy. Pediatr Nephrol. 2007; 22: 981–986
   PubMed Web of Science ®Google Scholar
• Barr RG, Seliger S, Appel GB, et al. Prognosis in proliferative lupus nephritis: The role of socioeconomic status and race/ethnicity. Nephrol Dial Transplant. 2003; 18: 2039–2046
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Maccario M, Banfi G, Ponticelli C. “Nephritic flares” are predictors of bad longterm renal outcome in lupus nephritis. Kidney Int. 1996; 50: 2047–2053
   PubMed Web of Science ®Google Scholar
• Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: A longitudinal study of prognostic factors and therapy. J Am Soc Nephrol. 1996; 7: 924–929
   PubMed Web of Science ®Google Scholar
• Cameron JS. Lupus nephritis. J Am Soc Nephrol. 1999; 10: 413–424
   PubMed Web of Science ®Google Scholar
• Carlavilla A, Gutierrez E, Ortuno T, Morales E, Gonzalez E, Praga M. Relapse of lupus nephritis more than 10 years after complete remission. Nephrol Dial Transplant. 2005; 20: 1994–1998
   Google Scholar